Anxiety epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
*Patients of all age groups may develop [[anxiety]]. | *Patients of all age groups may develop [[anxiety]]. | ||
*The median age at diagnosis is [11] years. | *The median age at diagnosis is [11] years. | ||
===Race=== | |||
*[Anxiety] usually more commonly affects individuals of the non-Hispanic Whites. [non Hispanic blacks] individuals are 20% less likely to develop [anxiety], Hispanics are 30% less likely to experience an anxiety disorder during their life time | *[Anxiety] usually more commonly affects individuals of the non-Hispanic Whites. [non Hispanic blacks] individuals are 20% less likely to develop [anxiety], Hispanics are 30% less likely to experience an anxiety disorder during their life time | ||
===Gender=== | ===Gender=== | ||
Revision as of 14:53, 21 August 2017
|
Anxiety Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anxiety epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Anxiety epidemiology and demographics |
|
Risk calculators and risk factors for Anxiety epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Prevalence
The prevalence of anxiety disorders is estimated to 28800 per 100,000 (28.8%)individuals[1]
Age
- Patients of all age groups may develop anxiety.
- The median age at diagnosis is [11] years.
Race
- [Anxiety] usually more commonly affects individuals of the non-Hispanic Whites. [non Hispanic blacks] individuals are 20% less likely to develop [anxiety], Hispanics are 30% less likely to experience an anxiety disorder during their life time
Gender
- Anxiety is more prevalent in females than in males. The male to female ratio is approximately 3 to2.[2]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005). "Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 629–40. doi:10.1001/archpsyc.62.6.629. PMID 15939840.
- ↑ Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 617–27. doi:10.1001/archpsyc.62.6.617. PMC 2847357. PMID 15939839.